Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. Other stock markets 09:10:14 11/08/2026 +03			5-day change	1st Jan Change
9.710 ^AUD	+0.94%		+7.06%	-22.07%

07-30	Clinuvel Pharmaceuticals Ltd Provides Commercial Update On Vitiligo And Reports Clinical Benchmarks For SCENESSE	CI
07-30	Clinuvel Pharmaceuticals Strengthens Supply Chain as Part of Commercial Preparations for North American Vitiligo Market	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	485.1	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-6.76%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	232.4	200.5	165.9
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-21.52%	-13.73%	-17.24%
P/E	63.4x	36.8x	30.3x	22x	14.5x	13.6x	12.9x	10.1x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.76x	1.58x	1.42x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-9.76x	2.27x	0.4x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	4.89x	4.64x	3.75x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.34x	1.92x	1.28x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	5.62x	4.52x	3.47x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	5.8x	4.64x	3.55x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	7.34x	5.52x	3x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	13.6%	18.1%	33.3%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.1114
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.64%	0.83%	1.16%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.708	0.7482	0.9547
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.64%	10.7%	11.7%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.21	104.6	129.3
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.39	44.34	47.75
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.05	43.25	46.76
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.72	37.66	48.15
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-252.7	-284.6	-319.2
Reference price ²	30.700	14.850	17.880	15.370	10.380	9.620	9.620	9.620
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21 A	8/30/22 A	8/29/23 A	8/28/24 A	8/27/25 A	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	13.59x	2.34x	5.62x	0.64%	343M
REGENERON PHARMACEUTICALS, INC.	19.09x	4.37x	10.28x	0.48%	80.69B
SAMSUNG BIOLOGICS CO.,LTD.	38.21x	13.07x	24.87x	-.--%	51.22B
UCB	22.71x	4.98x	14.44x	0.65%	49.58B
CSL LIMITED	-61.04x	3.52x	10.42x	3.01%	45.5B
BIOGEN INC.	36.8x	3.41x	12.97x	-.--%	30.6B
INCYTE CORPORATION	54.24x	3.43x	26.59x	-.--%	24.64B
MODERNA, INC.	-6.97x	9.6x	-6.2x	-.--%	23.88B
INNOVENT BIOLOGICS, INC.	72.93x	6.99x	45.98x	-.--%	21.59B
ALTEOGEN INC.	55.77x	51.21x	64.37x	0.13%	17.09B
Average	24.53x	10.29x	20.93x	0.49%	34.51B
Weighted average by Cap.	19.34x	8.33x	18.23x	0.61%